Cooper C. Collins is Chief Strategic Officer at PERNIX THERAPEUTICS HOLDINGS, INC. (PTX). They have made 10 open-market trades across 2 companies since 2011, most recently 2025-02-18.
CIK 0001485508
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
8 open-market purchases totalling $1.7M since 2014, against 2 sales. Across 8 scored buys the stock is down 16.3% at ninety days, and 19.3 points behind the S&P over the same stretch.
8 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 13% | 25% | 13% |
| Avg Move | -10.9% | -8.9% | -16.3% |
| Alpha | -9.3% | -9.9% | -19.3% |
| Scored | 8 | 8 | 8 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TXMD | BUY | 2024-08-22 | 2024-08-26 | $1.73 | $7K | -10.4% | -17.1% | -28.0% |
| TXMD | BUY | 2024-08-21 | 2024-08-23 | $1.70 | $2K | +1.7% | -3.4% | -24.0% |
| TXMD | BUY | 2021-11-18 | 2021-11-22 | $0.58 | $580K | -22.4% | -30.5% | -63.6% |
| TXMD | BUY | 2021-08-17 | 2021-08-19 | $0.73 | $725K | -2.0% | -17.2% | -29.2% |
| TXMD | BUY | 2020-06-08 | 2020-06-10 | $1.45 | $107K | -12.5% | +10.3% | -2.2% |
| TXMD | BUY | 2019-05-13 | 2019-05-15 | $3.33 | $100K | -6.8% | -24.9% | -8.0% |
| TXMD | BUY | 2016-03-11 | 2016-03-14 | $6.23 | $100K | -8.6% | +13.2% | +25.4% |
| TXMD | BUY | 2014-06-05 | 2014-06-09 | $3.84 | $77K | -26.4% | -1.1% | -1.1% |
| PTX | SELL · 10b5-1 | 2014-04-01 | 2014-04-02 | $5.26 | $473K | +1.5% | +5.9% | +5.9% |
| PTX | SELL · 10b5-1 | 2014-03-03 | 2014-03-05 | $3.41 | $12.2M | +1.5% | +5.9% | +5.9% |
| PTX | SELL · 10b5-1 | 2014-02-03 | 2014-02-05 | $2.22 | $200K | +1.5% | +5.9% | +5.9% |
| PTX | SELL · 10b5-1 | 2014-01-07 | 2014-01-08 | $2.20 | $62K | +1.5% | +5.9% | +5.9% |
| PTX | SELL · 10b5-1 | 2014-01-02 | 2014-01-06 | $2.35 | $146K | +1.5% | +5.9% | +5.9% |
| PTX | SELL · 10b5-1 | 2013-12-05 | 2013-12-10 | $2.31 | $87K | +1.5% | +5.9% | +5.9% |
| PTX | SELL · 10b5-1 | 2013-12-02 | 2013-12-04 | $2.44 | $128K | +1.5% | +5.9% | +5.9% |
| PTX | SELL · 10b5-1 | 2013-11-01 | 2013-11-05 | $2.00 | $180K | +1.5% | +5.9% | +5.9% |
| PTX | SELL · 10b5-1 | 2013-10-04 | 2013-10-08 | $2.47 | $58K | +1.5% | +5.9% | +5.9% |
| PTX | SELL · 10b5-1 | 2013-10-01 | 2013-10-03 | $2.54 | $170K | +1.5% | +5.9% | +5.9% |
| TXMD | SELL | 2013-06-14 | 2013-06-17 | $1.75 | $4.6M | -26.4% | -1.1% | -1.1% |
| PTX | SELL | 2011-07-21 | 2011-07-25 | $7.00 | $3.5M | +1.5% | +5.9% | +5.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.